OnDeck, part of Enova International, has introduced an AI-driven automated decision system for small business loans that delivers approval decisions in under a minute, often without requiring additional documentation. This upgrade aims to simplify and speed up the loan process, helping more small businesses access capital quickly. The system builds on OnDeck's existing underwriting standards and reflects the growing adoption of AI among small businesses. OnDeck plans to expand this technology to new customers and showcase it at upcoming finance events.
OnDeck's new AI-driven loan approval system is the subject here, with Pluang providing a snapshot of the Financials sector. Of 85 US financial stocks priced on Pluang, 12 rose and 70 fell as of Oct 08, 2026 18:12 WIB. Notable movements include Franklin Resources, Inc. (BEN) at USD 33.23 with a 1-day change of +2.31%, Futu Holdings Ltd (FUTU) at USD 107.30 down 2.17%, and Upstart Holdings Inc (UPST) at USD 23.50 down 2.16%.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
